Login / Signup

Analysis of circulating tumor DNA identifies distinct therapeutic response to intraperitoneal and intravenous paclitaxel plus S-1 in gastric cancer patients with peritoneal metastasis.

Hong YuanFei XuShengzhou WangDi LiuHuan ZhangJun ZhangMin ShiChao YanZhenggang Zhu
Published in: Therapeutic advances in medical oncology (2024)
ChiCTR-IIR-16009802 (Chinese Clinical Trial Registry).
Keyphrases
  • circulating tumor
  • clinical trial
  • cell free
  • circulating tumor cells
  • genome wide
  • high dose
  • phase ii
  • open label
  • double blind
  • study protocol
  • phase iii
  • randomized controlled trial